John Campbell, Ph.D., on his YouTube show examined the new clinical trials being conducted by the National Institutes of Health for a universal mRNA flu vaccine and questioned why contracts for new “unproved, undemonstrated, unresearched” vaccines are moving forward while basic questions about safety and efficacy remain unaddressed.

The National Institutes of Health is running a Phase 1 clinical trial on an experimental mRNA universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center. Although the vaccine is only in very early clinical trials, the U.K. government already has committed to a £1 billion deal with Moderna to buy the mRNA vaccines for flu and other respiratory viruses over the next 10 yearsJohn Campbell, Ph.D., reported on his YouTube show.

“This really is quite bizarre in my view,” said Campbell, “Why don’t we get the trial data first and then think about giving the thousand million pounds [£1 billion]” for the mass manufacture of the vaccines, he asked.